TxAgent is a web-based AI-driven platform designed to accelerate translational research and clinical decision support by analyzing multi-omics and clinical datasets. Users upload patient gene expression or mutation profiles, configure disease context and drug libraries, and run an automated pipeline that integrates network biology, machine learning models, and drug-target interaction databases. The agent returns ranked lists of single and combination therapies, toxicity-adjusted scores, pathway enrichment analyses, and interactive network visualizations to guide experimental design and therapeutic hypotheses.

AI-Twin is a cutting-edge technology that fuses engineered 3D multi-tissue constructs, derived from patient biopsies, with digital twins. These computational models simulate biological behavior, providing an advanced platform for personalized medicine, biomedical research, and clinical applications. AI-Twin stands at the forefront of healthcare innovation, accelerating the pathophysiological understanding and the development of individualized treatments.

Apollo Health AI develops advanced artificial intelligence solutions that assist healthcare providers in personalizing patient care, predicting health risks, and optimizing clinical decisions. This platform integrates machine learning and data analytics to deliver insights that enhance healthcare outcomes, streamline workflows, and reduce costs for healthcare professionals. By utilizing real-time data and predictive modeling, Apollo Health AI empowers providers to proactively manage patient health and improve clinical effectiveness.

Co Doctor is an AI-powered assistant that acts as your personalized twin in the healthcare field. By collecting comprehensive patient data during pre-consultation, analyzing this information to generate custom treatment plans during the consultation, and executing these plans while monitoring patient progress post-consultation, Co Doctor ensures a thorough, efficient, and personalized process for both healthcare professionals and patients.

Cyber Doctor leverages advanced natural language processing to interactively gather user symptoms, medical history, and lifestyle data, then analyzes this information to generate tailored diagnostic suggestions. It cross-references up-to-date clinical guidelines, medical literature, and real-world patient data for evidence-based recommendations. The agent assesses triage urgency, suggests personalized self-care measures, and monitors symptom progression over time via regular check-ins. It integrates seamlessly with electronic health record systems and wearable devices through secure APIs, enabling healthcare professionals to track patient inputs and outcomes. Cyber Doctor also supports symptom trend analysis and multilingual consultations to broaden accessibility. It maintains strict HIPAA-compliant privacy protections, offers proactive health alerts for worsening conditions, and includes customizable modules for specific specialties. Users can export anonymized reports for further clinical review or research purposes.

Doctronic is an AI-driven platform that offers personalized health insights, triage and care navigation, and the ability to book video visits with licensed doctors. It provides fast, free, and secure consultations to help you better understand your health, and offers a convenient way to get medical care and advice 24/7.

Sema4.ai utilizes advanced AI technologies to analyze genomic and health data, enabling healthcare providers to make informed decisions. The platform focuses on improving patient outcomes through personalized insights derived from complex datasets, ensuring that healthcare providers can tailor treatments based on individual patient needs. By integrating diverse data sources, Sema4.ai empowers healthcare professionals to deliver precise and efficient care.

Unlearn.AI provides a groundbreaking product that leverages artificial intelligence to transform clinical trials. Utilizing digital twin technology, Unlearn.AI enables medical researchers to conduct quicker and more accurate clinical trials. By virtually simulating patients, this technology reduces the need for large control groups, enhances trial efficiency, and accelerates the development of personalized medical treatments. This approach not only saves time and resources but also improves the accuracy and reliability of clinical trials.

先見基因科技 specializes in genetic testing that empowers individuals with detailed insights into their health risks and genetic predispositions. By leveraging state-of-the-art technology and a highly qualified research team, the company provides actionable health information, enabling personalized medical strategies. Their focus on high-throughput sequencing technology aids in delivering precise risk assessments for various diseases, ensuring that individuals can make informed health-related choices.